Related references
Note: Only part of the references are listed.Structurally restricted Bi(III) metallation of apo-βMT1a: metal-induced tangling
Natalie C. Korkola et al.
METALLOMICS (2021)
Ion Activation Methods for Peptides and Proteins
Luis A. Macias et al.
ANALYTICAL CHEMISTRY (2020)
Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl2 Complexes
Dianna Truong et al.
INORGANIC CHEMISTRY (2020)
Top-down mass spectrometry reveals multiple interactions of an acetylsalicylic acid bearing Zeise's salt derivative with peptides
Monika Cziferszky et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2020)
Distinguishing Isomeric Aromatic Radical Cations by Using Energy-Resolved Ion Trap and Medium Energy Collision-Activated Dissociation Mass Spectrometry
Mark Romanczyk et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2020)
Metallocomplex-Peptide Interactions Studied by Ultrahigh Resolution Mass Spectrometry
Cookson K. C. Chiu et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2020)
Reactions of Medicinal Gold(III) Compounds With Proteins and Peptides Explored by Electrospray Ionization Mass Spectrometry and Complementary Biophysical Methods
Lara Massai et al.
FRONTIERS IN CHEMISTRY (2020)
A Combined Spectroscopic and Protein Crystallography Study Reveals Protein Interactions of RhI(NHC) Complexes at the Molecular Level
Isabelle M. Daubit et al.
INORGANIC CHEMISTRY (2020)
Metalloproteomics for molecular target identification of protein-binding anticancer metallodrugs
Tasha R. Steel et al.
METALLOMICS (2020)
Expanding medicinal chemistry into 3D space: metallofragments as 3D scaffolds for fragment based drug discovery
Christine N. Morrison et al.
CHEMICAL SCIENCE (2020)
Metal Drugs and the Anticancer Immune Response
Bernhard Englinger et al.
CHEMICAL REVIEWS (2019)
Anti-cancer organoruthenium(II) complexes and their interactions with cysteine and its analogues. A mass-spectrometric study
Anamarija Bris et al.
DALTON TRANSACTIONS (2019)
Structural analysis of peptides modified with organo-iridium complexes, opportunities from multi-mode fragmentation
Christopher A. Wootton et al.
ANALYST (2019)
Selective targeting of PARP-1 zinc finger recognition domains with Au(III) organometallics
Margot N. Wenzel et al.
CHEMICAL COMMUNICATIONS (2018)
Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development
Samuel M. Meier-Menches et al.
CHEMICAL SOCIETY REVIEWS (2018)
Sequence-dependent attack on peptides by photoactivated platinum anticancer complexes
Christopher A. Wootton et al.
CHEMICAL SCIENCE (2018)
Zeise's salt as powerful platinating agent for proteins investigated by top-down-mass spectrometry
Monika Cziferszky et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2018)
From Catalysis to Cancer: Toward Structure-Activity Relationships for Benzimidazol-2-ylidene-Derived N-Heterocyclic-Carbene Complexes as Anticancer Agents
Nelson Y. S. Lam et al.
INORGANIC CHEMISTRY (2018)
Characterization of Lipid A Variants by Energy-Resolved Mass Spectrometry: Impact of Acyl Chains
Christopher M. Crittenden et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2017)
Mass spectrometry as a powerful tool to study therapeutic metallodrugs speciation mechanisms: Current frontiers and perspectives
Margot Wenzel et al.
COORDINATION CHEMISTRY REVIEWS (2017)
DNA or protein? Capillary zone electrophoresismass spectrometry rapidly elucidates metallodrug binding selectivity
Christian Artner et al.
CHEMICAL COMMUNICATIONS (2017)
An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin
Samuel M. Meier et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
The metalation of hen egg white lysozyme impacts protein stability as shown by ion mobility mass spectrometry, differential scanning calorimetry, and X-ray crystallography
Matthew P. Sullivan et al.
CHEMICAL COMMUNICATIONS (2017)
Mass spectrometric studies on the interaction of cisplatin and insulin
Jing Li et al.
AMINO ACIDS (2016)
Mapping the protein-binding sites for iridium(III)-based CO-releasing molecules
Marco Caterino et al.
DALTON TRANSACTIONS (2016)
Mass Spectrometry Uncovers Molecular Reactivities of Coordination and Organometallic Gold(III) Drug Candidates in Competitive Experiments That Correlate with Their Biological Effects
Samuel M. Meier et al.
INORGANIC CHEMISTRY (2016)
Binding of an organo-osmium(II) anticancer complex to guanine and cytosine on DNA revealed by electron-based dissociations in high resolution Top-Down FT-ICR mass spectrometry
Christopher A. Wootton et al.
DALTON TRANSACTIONS (2015)
Insights on the mechanism of thioredoxin reductase inhibition by Gold N-heterocyclic carbene compounds using the synthetic linear Selenocysteine containing C-terminal peptide hTrxR(488-499): An ESI-MS investigation
Alessandro Pratesi et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
Insights into the Binding Sites of Organometallic Ruthenium Anticancer Compounds on Peptides Using Ultra-High Resolution Mass Spectrometry
Rebecca H. Wills et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2014)
Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs
Christian G. Hartinger et al.
CHEMICAL SOCIETY REVIEWS (2013)
Mapping the protein-binding sites for novel iridium(III) anticancer complexes using electron capture dissociation
Yulin Qi et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2013)
Novel metal(II) arene 2-pyridinecarbothioamides: a rationale to orally active organometallic anticancer agents
Samuel M. Meier et al.
CHEMICAL SCIENCE (2013)
Biomolecule binding vs. anticancer activity: Reactions of Ru(arene)[(thio)pyr-(id)one] compounds with amino acids and proteins
Samuel M. Meier et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Determination of the relative ligand-binding strengths in heteroleptic IrIII complexes by ESI-Q-TOF tandem mass spectrometry
Esra Altuntas et al.
JOURNAL OF MASS SPECTROMETRY (2012)
Gold compounds as therapeutic agents for human diseases
Susan J. Berners-Price et al.
METALLOMICS (2011)
Ruthenium versus platinum: interactions of anticancer metallodrugs with duplex oligonucleotides characterised by electrospray ionisation mass spectrometry
Michael Groessl et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2010)
The challenges of determining metal-protein affinities
Zhiguang Xiao et al.
NATURAL PRODUCT REPORTS (2010)
Top-Down Mass Spectrometric Approach for the Full Characterization of Insulin-Cisplatin Adducts
Estefania Moreno-Gordaliza et al.
ANALYTICAL CHEMISTRY (2009)
Exploring metallodrug-protein interactions by mass spectrometry: comparisons between platinum coordination complexes and an organometallic ruthenium compound
Angela Casini et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2009)
High Resolution Mass Spectrometry for Studying the Interactions of Cisplatin with Oligonucleotides
Alexander E. Egger et al.
INORGANIC CHEMISTRY (2008)
Stability of an organometallic ruthenium-ubiquitin adduct in the presence of glutathione: Relevance to antitumour activity
Christian G. Hartinger et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
Ruthenium anticancer drugs and proteins:: a study of the interactions of the ruthenium(III) complex imidazolium trans-[tetrachloro(dimethyl sulfoxide)(imidazole)ruthenate(III)] with hen egg white lysozyme and horse heart cytochrome c
Angela Casini et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2007)
Interactions of antitumor metallodrugs with serum proteins: Advances in characterization using modern analytical methodology
Andrei R. Timerbaev et al.
CHEMICAL REVIEWS (2006)
A mass spectrometric and molecular modelling study of cisplatin binding to transferrin
I Khalaila et al.
CHEMBIOCHEM (2005)
Binding of organometallic ruthenium(II) and osmium(II) complexes to an oligonucleotide: A combined mass spectrometric and theoretical study
A Dorcier et al.
ORGANOMETALLICS (2005)
Relative binding energies of gas-phase pyridyl ligand/metal complexes by energy-variable collisionally activated dissociation in a quadrupole ion trap
M Satterfield et al.
INORGANIC CHEMISTRY (2001)
Molecular recognition and supramolecular chemistry in the gas phase
CA Schalley
MASS SPECTROMETRY REVIEWS (2001)
Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent
JN Burstyn et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
